Kuehne + Nagel continously enhances quality of its pharma logistics services

(PresseBox) ( Contern, LU, )
Kuehne + Nagel has expanded its specialty trailer network in Belgium and Luxembourg by investing in 50 temperature-controlled pharma trailers to offer its customers state-of-the-art equipment that ensures the quality of their pharmaceutical products from pick-up to delivery.

The specialty trailers are manufactured with aggregates that guarantee temperature control at all times through new built-in DAC (Discharge Air Control) and PTC (Precision Temperature Control) technology. Moreover, it protects the cargo from any temperature deviation which is a key industry requirement. With temperature accuracy improvement, the set point bandwidth has been reduced by 80 per cent and the temperature sensitivity control has been improved in the remote zone of the trailer. It reduces the risk of pharmaceutical products being damaged by frost. Kuehne + Nagel is one of the first logistics providers equipped with such a large number of temperature-controlled trailers for serving the pharmaceutical industry – in the meantime grown to a number of more than 100 in Europe.

"We are committed to investing in best-in-class equipment to ensure our customers’ products arrive at their destination safe and completely intact through shipping fully compliant according to temperature guidelines", Kevin Nash, Managing Director Kuehne + Nagel Belgium & Luxembourg. "The expansion further solidifies KN PharmaChain as a leading pharma logistics service in Europe and as part of our global network."
Für die oben stehenden Pressemitteilungen, das angezeigte Event bzw. das Stellenangebot sowie für das angezeigte Bild- und Tonmaterial ist allein der jeweils angegebene Herausgeber (siehe Firmeninfo bei Klick auf Bild/Meldungstitel oder Firmeninfo rechte Spalte) verantwortlich. Dieser ist in der Regel auch Urheber der Pressetexte sowie der angehängten Bild-, Ton- und Informationsmaterialien.
Die Nutzung von hier veröffentlichten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Bei Veröffentlichung senden Sie bitte ein Belegexemplar an service@pressebox.de.